Inflammation | Xconomy

by in

Entry	Blogger	Date	Location
Omeros Moves Closer To IPO, Sets Price Goal	Luke Timmerman	09/16/09	Seattle
Lankau New CEO at Logical	Ryan McBride	05/11/09	Boston
Pfizer’s VC Leader, Barbara Dalton, on Corporate Venture and Northwest Deal Hunting	Luke Timmerman	03/17/09	Seattle
Calistoga Reunites Icos Execs To Pursue Cancer, Inflammation Drugs	Luke Timmerman	03/11/09	Seattle
Meritage Starts Study of Inflammatory Disease	Luke Timmerman	01/22/09	San Diego
Qwell Pharmaceuticals, Backed by Arch, Raises $7M for New Cancer, Inflammation Drugs	Luke Timmerman	01/06/09	Seattle
Another Next-Generation RNAi Startup Emerges, Makes Big Claims About Its Ability to Silence Bad Genes	Ryan McBride	12/18/08	Boston
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge	Luke Timmerman	08/14/08	Boston
Novo Nordisk Returning to Seattle, Hiring 80 People by 2010	Luke Timmerman	08/05/08	Seattle
Page 1 of 1

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.